American journal of infection control · 2024
Elizabethkingia meningoseptica in Dubai, United Arab Emirates: A 7-year multicenter study.
СтатьяМногоцентровое исследованиеНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Alsayed Hawra Ali Hussain, Saheb Sharif-Askari Narjes, Saheb Sharif-Askari Fatemeh, Halwani Rabih
Аннотация
BACKGROUND: Elizabethkingia meningoseptica (E. meningoseptica) is a gram-negative bacillus. Widely distributed in nature, it poses a significant threat as a nosocomial pathogen, particularly affecting immunocompromised neonates and the elderly.
METHODS: This study aimed to describe the antimicrobial susceptibility and outcomes of E. meningoseptica infections over seven years in United Arab Emirates. A retrospective chart review study was conducted at four hospitals that are part of Dubai Academic Health Corporation.
RESULTS: A total of 23 cases were observed during the study, 21 (91%) of which exhibited multidrug resistance. More than half of the cases required intensive care and mechanical ventilation (n = 13, 57%). The in-hospital mortality rate was 38% (n = 5) in adults and 20% (n = 2) in pediatrics.
CONCLUSIONS: E. meningoseptica is a significant nosocomial pathogen with high antibiotic resistance, posing severe risks to immunocompromised pediatric and adult patients. Effective management of E. meningoseptica requires vigilant monitoring, comprehensive control, and targeted therapies.
METHODS: This study aimed to describe the antimicrobial susceptibility and outcomes of E. meningoseptica infections over seven years in United Arab Emirates. A retrospective chart review study was conducted at four hospitals that are part of Dubai Academic Health Corporation.
RESULTS: A total of 23 cases were observed during the study, 21 (91%) of which exhibited multidrug resistance. More than half of the cases required intensive care and mechanical ventilation (n = 13, 57%). The in-hospital mortality rate was 38% (n = 5) in adults and 20% (n = 2) in pediatrics.
CONCLUSIONS: E. meningoseptica is a significant nosocomial pathogen with high antibiotic resistance, posing severe risks to immunocompromised pediatric and adult patients. Effective management of E. meningoseptica requires vigilant monitoring, comprehensive control, and targeted therapies.
Предметные рубрики MeSH
HumansUnited Arab EmiratesFlavobacteriaceae InfectionsRetrospective StudiesMaleAdultFemaleMiddle AgedInfantChild, PreschoolAgedCross InfectionChildAdolescentAnti-Bacterial AgentsYoung AdultMicrobial Sensitivity TestsInfant, NewbornDrug Resistance, Multiple, BacterialChryseobacteriumAged, 80 and overFlavobacteriaceaeTreatment Outcome